Status:
ACTIVE_NOT_RECRUITING
A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging
Lead Sponsor:
VA Office of Research and Development
Conditions:
Prostate Cancer
Eligibility:
All Genders
Phase:
NA
Brief Summary
The primary aim of this study is to determine whether a multi-modal, physician-focused behavioral intervention can improve facility-level guideline-concordant utilization of prostate cancer staging im...
Detailed Description
Almost half of Veterans with localized prostate cancer (the most common non-cutaneous malignancy among US men) receive inappropriate, wasteful imaging. The VHA Blueprint for Excellence prioritizes inc...
Eligibility Criteria
Inclusion
- Provider Criteria:
- Urology Chiefs and attending urologists employed through the VA (full time, part time) at one of the 10 participating sites
- Physician Assistants and Nurse Practitioners employed through the VA at one of the 10 participating sites that work in the respective urology clinics
- Providers may be any gender or race/ethnicity
- Qualitative portion only:
- Urology Chiefs and/or frontline staff physicians
- participating PAs \& NPs having cared for at least 5 men with incident prostate cancer within the previous 6 months
- Patients will not be directly recruited into the study.
- The investigators have obtained a waiver of HIPAA authorization and informed consent to analyze electronic health records of patients that are diagnosed with ICD-9 code 185 or ICD-10 code C61 during the study period at the 10 participating sites.
Exclusion
- Provider Criteria:
- Urology Residents will be excluded.
- Patients
- Patients will be excluded if they have a history of prior malignancy
- Are over the age of 85
- Diagnosed at autopsy or by death certificate
- Died within 3 months of diagnosis
- Not having data on at least one of the following:
- PSA
- clinical stage
- Gleason score
Key Trial Info
Start Date :
April 9 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2026
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT03445559
Start Date
April 9 2018
End Date
February 28 2026
Last Update
July 28 2025
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, California, United States, 94304-1207
2
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
West Los Angeles, California, United States, 90073-1003
3
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
West Haven, Connecticut, United States, 06516-2770
4
Minneapolis VA Health Care System, Minneapolis, MN
Minneapolis, Minnesota, United States, 55417-2309